[Cardiopulmonary capacity in patients with coronary heart disease].
Cardiopulmonary exercise testing (CPX) allows a non-invasive control of the cardiopulmonary exercise capacity. In this study, we wanted to investigate if the CPX can be securely, practicably, and accurately performed in patients with invasively documented coronary heart disease (CHD). Furthermore, we wanted to find out the clinical value of CPX in CHD diagnosis. The CPX measurements (symptom-limited; ramp program with 20 Watts increase/min; semi-supine position; continuous registration of the cardio-circulatory parameters (HR, RR, ECG), of the gas exchange parameters (O2, CO2) and of the ventilation) in 101 patients have shown that CPX is secure, accurate, and practicable. The day-to-day reproducibility is high (r > 0.8). The respiratory anaerobic threshold can be manually evaluated by means of the PET O2 criterion in 95% of the cases. The CCS-classification of angina pectoris could not accurately describe the cardiopulmonary exercise capacity as compared to the Weber-classification. The disadvantage of the Weber-classification is that it does not respect the age-, sex- and weight-dependent differences of the normal values. Our own data and results from the literature demonstrate that the anaerobic threshold, the maximum VO2 and the maximum O2-pulse are the more reduced the more coronary arteries are involved, the more reduced the left ventricular function is. But, nevertheless, the range of values shows large overlaps so that an exact differentiation, based upon these parameters, is not possible. Patients with similar functional results or degree of reduced exercise capacity have different morphological alterations. Most patients demonstrated typical ischemic cascade with anaerobic threshold, ST-segment alterations, angina pectoris and, finally, reduced max. VO2. In conclusion, CPX does not replace the traditional methods of non-invasive and invasive ischemia detection, but enables secure, practicable, and accurate measurements of the individual cardiopulmonary exercise capacity and the interaction between muscles, heart, circulation, and lungs. Possibly, CPX can be used in the near future for identifying CHD patients with low, medium or high risk.
Winter
U J
UJ
Klinik III für Innere Medizin, Universität zu Köln.
Gitt
A K
AK
Blaum
M
M
Fritsch
J
J
Berge
P G
PG
Pothoff
G
G
Hilger
H H
HH
D000328:Adult; D000368:Aged; D015308:Anaerobic Threshold / Q000502:physiology; D000787:Angina Pectoris / Q000145:classification / Q000175:diagnosis / Q000503:physiopathology; D001794:Blood Pressure / Q000502:physiology; D003327:Coronary Disease / Q000145:classification / Q000175:diagnosis / Q000503:physiopathology*; D004562:Electrocardiography / Q000295:instrumentation / Q000706:statistics & numerical data*; D005080:Exercise Test / Q000295:instrumentation / Q000706:statistics & numerical data*; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D008176:Lung Volume Measurements; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000145:classification / Q000175:diagnosis / Q000503:physiopathology; D010100:Oxygen / Q000502:physiology; D011659:Pulmonary Gas Exchange / Q000502:physiology; D012016:Reference Values; D015203:Reproducibility of Results; D012815:Signal Processing, Computer-Assisted; D013147:Spirometry / Q000295:instrumentation / Q000706:statistics & numerical data*; D016277:Ventricular Function, Left / Q000502:physiology
D010100:Oxygen
Kardiopulmonale Leistungsfähigkeit bei Patienten mit koronarer Herzkrankheit.